Jacqueline Mercier > Goodwin > Boston, United States > Lawyer Profile

Goodwin
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
Jacqueline Mercier photo

Position

Partner

Career

Jacqueline Mercier is a partner in the firm’s Business Law department and a member of Goodwin’s Technology and Life Sciences groups and a member of the Goodwin Life Sciences and Public Company Advisory practices, where she is co-chair of the Private M&A team and the Structured Financing and Royalty Monetization practice. Jacqueline focuses her practice on late-stage and publicly traded company representation, including in matters related to corporate governance, mergers and acquisitions, royalty-based financings and other complex transactions, securities offerings, securities law compliance, proxy contests, and general corporate matters. Jacqueline originally joined Goodwin in 2007.

Education

JD, Boston College Law School 2007 / BS, Boston College 2000

Lawyer Rankings

United States > M&A/corporate and commercial > M&A: middle-market ($500m-999m)

Displaying broad expertise across the whole spectrum of corporate transactions, including cross-border acquisitions, divestitures, and leveraged buyouts, the Goodwin team is heavily praised for its ‘extremely smart, capable, and well-informed’ approach. The practice frequently provides strategic counsel on various shareholder-related issues, including proxy contests, activism, and shareholder litigation, with Boston-based global chair of M&A Stuart Cable noted as an expert in the life sciences sector. Lisa Haddad routinely represents buyers, sellers, and financial advisors, while Jacqueline Mercier focuses on complex corporate governance issues. Also based out of Boston, John Haggerty and Deborah Birnbach co-chair the public M&A offering. From Silicon Valley, Lawrence Chu brings vast experience in handling joint venture arrangements and recapitalizations, while New York-based Joshua Zachariah is highly knowledgeable in the tech and private equity spheres. Alessandra Love Simons left the firm in November 2023.